Mölnlycke latest news

Being a provider of medical devices for health care professionals – many of which are critically needed to combat the evolving COVID-19 situation –...

Zlatko Rihter has been appointed President and CEO of the medical solutions company, Mölnlycke Health Care AB.

AstraZeneca’s BioVentureHub announced today that it has established a new collaboration with Mölnlycke, a global medtech company headquartered in...

The Medical Device Regulation (MDR) – which was due to enter into force in May this year –will replace the Medical Device Directive in Europe and is muc...

Mölnlycke takes pride in having a highly trained workforce as many of our employees have a clinical background. 

By utilising its extensive global supplier network, the world-leading medical solutions company, Mölnlycke has managed to contract suppliers for...

Thanks to crucial efforts by the Swedish Prime Minister Stefan Löfven and several other parties, the French government has today decided to lift the...

Richard Twomey, President and CEO of Mölnlycke, will after six years leave the organisation.

New report shows Granulox ® (Mölnlycke), an innovative topical haemoglobin spray, is a cost-effective therapy in chronic wound care management as adjunc...